|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 15-08-04 | Hospira : Pfizer wins EU approval for $15 billion Hospira buy | RE |
| 15-07-27 | Allergan : Mylan independence from Teva's embrace comes with a price | RE |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | - | - | - | - | - | 0 | |
| 0.91% | 1.06% | 34.73x | 4.87x | 6.51x | 22.55x | 27.28x | 47.23B | |
| 1.37% | 1.46% | 18.54x | 1.93x | 2.19x | 9.99x | 12.87x | 39.62B | |
| 0.91% | 1.03% | 27.87x | 3.08x | 3.39x | 17.56x | 22.52x | 12.09B | |
| 0.6% | 0.63% | 27.13x | 3.74x | 3.88x | 16.07x | 22.5x | 11.8B | |
| 3.85% | 3.94% | 18.73x | 3.25x | 3.33x | 11.58x | 13.79x | 9.12B | |
| 4.42% | 5.14% | 9.11x | 1.57x | 2.11x | 5.48x | 6.75x | 7.57B | |
| 3.25% | 3.22% | 15.69x | 1.29x | 2.04x | 6.63x | 9.53x | 7.1B | |
| 0.16% | 0.17% | 28.33x | 5.2x | 3.7x | 17.19x | 20.73x | 6.87B | |
| 0.9% | 1.03% | 37.01x | 8.57x | 7.24x | 26.4x | 29.15x | 4.86B | |
| 3.33% | 3.83% | 15.97x | 2.61x | 2.58x | 12.03x | 11.66x | 4.05B | |
| 1.87% | 1.77% | 14.42x | 0.7x | 2.02x | 8.64x | 10.92x | 3.9B | |
| 2.65% | 2.72% | 14.94x | 3.01x | 3.48x | 13x | 14.36x | 2.97B | |
| 3.2% | 3.56% | 18.8x | 5.04x | 5.86x | 16.65x | 18.02x | 2.61B | |
| Average | 2.11% | 2.27% | 21.64x | 3.45x | 3.72x | 14.14x | 16.93x | 11.41B | |
| Weighted average by Cap. | 1.56% | 1.7% | 24.86x | 3.45x | 4.05x | 15.44x | 19.05x |
- Stock Market
- Stocks
- Stock
- Sector Hospira, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
